Martin Shkreli launched 'unmonitored' trial in Cyprus for Retrophin drug without FDA oversight
March 06, 2018 at 17:25 PM EST
Shkreli's "insistence on taking shortcuts" in order to get a PKAN drug to market "drastically delayed the development of the drug," prosecutors said.